Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar mkllo (< 20) Submitted: 11/19/2011 8:11:51 PM : Outperform Start Price: $52.62 REGN Score: +141.28

just had drug approved

Featured Broker Partners


Advertisement